Contera Pharma
-
2010
Company Description
Contera Pharma identifies and develops innovative treatments for patients suffering from movement disorders
Contera Pharma identifies and develops innovative treatments for patients suffering from movement disorders. They use their expertise in drug discovery and development in close collaboration with expert individuals and organizations to provide foundations for success. The lead project JM-010 is approved for Phase IIa clinical trials for treatment of dyskinesia associated with Parkinson's disease.
-
Manufacturer:
Science and Engineering -
Formed:
2010 -
Founders:
John Bondo Hansen -
Company Website:
-
Company E-mail:
-
Company Address:
Ole Maaløes Vej 3CopenhagenDenmark -
CEO:
- John Bondo Hansen
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits